ArticleInternational journal of surgery (London, England)2026
A multicenter parallel-group double-blind randomized placebo-controlled phase III clinical trial of generic aprepitant QLG2174 for the prevention of postoperative nausea and vomiting.
Peng Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.